These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7229114)

  • 21. Recent developments in noradrenergic neurotransmission and its relevance to the mechanism of action of certain antihypertensive agents.
    Langer SZ; Cavero I; Massingham R
    Hypertension; 1980; 2(4):372-82. PubMed ID: 6105128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroendocrine evaluation of catecholaminergic neurotransmission in mania.
    Ansseau M; von Frenckell R; Cerfontaine JL; Papart P; Franck G; Timsit-Berthier M; Geenen V; Legros JJ
    Psychiatry Res; 1987 Nov; 22(3):193-206. PubMed ID: 2829258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catecholamine reward pathways and schizophrenia: the mechanism of the antipsychotic effect and the site of the primary disturbance.
    Crow TJ
    Fed Proc; 1979 Oct; 38(11):2462-7. PubMed ID: 39790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.
    Strömbom U
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):167-76. PubMed ID: 181681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Definite and sustained improvement with pimozide of two patients with severe trigeminal neuralgia. Some neurochemical, neurophysiological and neuroendocrinological findings.
    Lechin F; van der Dijs B; Amat J; Lechin AE; Cabrera A; Lechin ME; Gómez F; Arocha L; Jiménez V
    J Med; 1988; 19(3-4):243-56. PubMed ID: 3183535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mice lacking the dopamine transporter display altered regulation of distal colonic motility.
    Walker JK; Gainetdinov RR; Mangel AW; Caron MG; Shetzline MA
    Am J Physiol Gastrointest Liver Physiol; 2000 Aug; 279(2):G311-8. PubMed ID: 10915639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of clonidine on growth hormone release in psychiatric patients and controls.
    Matussek N; Ackenheil M; Hippius H; Müller F; Schröder HT; Schultes H; Wasilewski B
    Psychiatry Res; 1980 Mar; 2(1):25-36. PubMed ID: 6251501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features: dopaminergic, noradrenergic and thyroid correlates.
    Sahoo M; Subho C
    Psychoneuroendocrinology; 2007 Feb; 32(2):210; author reply 211-2. PubMed ID: 17198745
    [No Abstract]   [Full Text] [Related]  

  • 29. Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder.
    Hewlett WA; Vinogradov S; Agras WS
    J Clin Psychopharmacol; 1992 Dec; 12(6):420-30. PubMed ID: 1474179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjunctive clonazepam treatment of tic symptoms in children with comorbid tic disorders and ADHD.
    Steingard RJ; Goldberg M; Lee D; DeMaso DR
    J Am Acad Child Adolesc Psychiatry; 1994; 33(3):394-9. PubMed ID: 8169185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noradrenergic terminals are the primary source of α
    Devoto P; Flore G; Saba P; Scheggi S; Mulas G; Gambarana C; Spiga S; Gessa GL
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():97-103. PubMed ID: 30472147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the role of the central noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat.
    Krulich L; Giachetti A; Marchlewska-Koj A; Hefco E; Jameson HE
    Endocrinology; 1977 Feb; 100(2):496-505. PubMed ID: 188629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological manipulations of the alpha 2-noradrenergic system. Effects on cognition.
    Coull JT
    Drugs Aging; 1994 Aug; 5(2):116-26. PubMed ID: 7981483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From pharmacological profiles to clinical outcomes.
    Kerwin R
    Int Clin Psychopharmacol; 2000 Dec; 15 Suppl 4():S1-4. PubMed ID: 11252517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The biochemical basis of relapse and drug response in schizophrenia: review and hypothesis.
    van Kammen DP
    Psychol Med; 1991 Nov; 21(4):881-95. PubMed ID: 1685791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjunctive clonazepam in the treatment of chronic schizophrenia.
    Herrera JM; Alvarez WA; Freinhar JP; Lawson WB; Sramek JJ
    Int J Psychosom; 1991; 38(1-4):17-20. PubMed ID: 1685726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydergine: interaction with the neurotransmitter systems in the central nervous system.
    Markstein R
    J Pharmacol; 1985; 16 Suppl 3():1-17. PubMed ID: 2869188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noradrenergic transmission and female sexual behavior of guinea pigs.
    Nock B; Feder HH
    Brain Res; 1979 Apr; 166(2):369-80. PubMed ID: 218695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of postprandial colonic motility by sulpiride in patients with irritable colon.
    Lanfranchi GA; Bazzocchi G; Marzio L; Campieri M; Brignola C
    Eur J Clin Pharmacol; 1983; 24(6):769-72. PubMed ID: 6884414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia.
    Masana M; Bortolozzi A; Artigas F
    Int J Neuropsychopharmacol; 2011 Feb; 14(1):53-68. PubMed ID: 20701825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.